These studies identify TOP2α as a critical regulator of HPV genome amplification upon differentiation as well as an auto-regulatory loop suggesting an auto-regulatory loop.
Abstract
High-risk human papillomaviruses (HPVs) are the etiological agents of over 5% of cancers worldwide including those of the cervix and oropharynx. HPVs infect stratified epithelia and establish latent infections in basal cells but restrict productive replication or amplification to differentiated suprabasal cells. Despite the presence of viral genomes in most differentiated cells, only a subset of cells amplifies genomes as well as express late genes and these correspond to those that have re-entered G2/M, but the factors regulating this selectivity are unknown. To determine the signals that control the productive viral life cycle, single cell RNA seq was performed on cells that stably maintain high-risk HPV genomes following differentiation. Ten populations of undifferentiated and differentiating keratinocytes were identified, however, only one differentiated population had entered G2/M, expressed late genes and amplified viral genomes. One of the highly expressed replication factors in this population was the type II topoisomerase TOP2α while no other topoisomerases were similarly induced. TOP2α was found to bind to viral genomes, and acute depletion in differentiating cells blocked entry into G2/M, impaired genome amplification and abrogated late gene expression. Amplification also requires activation of DNA repair pathways through the induction of high levels of DNA breaks, and TOP2α accounted for more than half of the breaks present in differentiating cells. Increases in levels of TOP2α in differentiating cells were driven by the E7 oncoprotein acting through the transcription factor FOXM1, which also controls expression of G2/M factors suggesting an auto-regulatory loop. These studies identify TOP2α as a critical regulator of HPV genome amplification upon differentiation.
Viruses cause 10%–15% of human cancers worldwide. Genomic instability, including DNA damage and the accumulation of mutations and aberrations, is the most common outcome of virus-induced reprogramming. One of the most infectious viruses that causes cancer and spreads sexually is the human papillomavirus (HPV). Mostly H...
N. Singh, Agrika Gupta, Aashi Saldhi et al.· Public Health - Open Journal· 1 citation
Persistent high-risk Human Papillomavirus (HPV) infection is a prerequisite for most cervical cancers, but only a subset of infections progress to invasive disease. This study investigated associations between HPV transcript abundance, malignant epithelial heterogeneity, inferred cell-state trajectories, and microenvir...
Han Zhang, Wei Chen, Ya-Ping Li et al.· Journal of Clinical Technolo...· 0 citations
Persistent infection with high-risk human papillomaviruses (hrHPVs) is a primary driver of cervical carcinogenesis, with the viral oncogenes E6 and E7 playing pivotal roles. Conventional nuclease-based gene-editing strategies are limited by genome-wide off-target effects and genomic perturbations associated with double...
Yue Kang, Yi-Fan Wu, Bing-Ting Bao et al.· Molecular Therapy· 0 citations
High‑risk (HR) human papillomaviruses (HPVs) rely on the continuous expression of the E6 and E7 oncoproteins to reshape epithelial biology, drive and sustain malignant transformation. The high‑risk E7 oncoprotein is multifunctional, and its phosphorylation by Casein Kinase II (CKII) is a key post translational modifica...
I. Gbala, O. Basukala, Amira Zine El Abidine et al.· PLoS Pathogens· 0 citations
This study systematically reviews sequencing platforms and their application for detecting structural variants and evaluates long-read assembly tools for reconstructing HPV integration structures, enabling a more comprehensive understanding of virus-driven genome remodeling in cancer.
Xin-Yi Deng, Xiao-Meng Du, E. Gensterblum-Miller et al.· Frontiers in Oncology· 0 citations
MYC is one of the most ubiquitous amplified oncogenes in human cancers. Roughly 30% of pancreatic adenocarcinoma (PDAC) samples show MYC amplification, which is associated with increased aggressiveness and drug resistance. Our recent single cell analysis of 62 primary PDAC showed that MYC amplification promotes class...
Qing Su, Andre Qin, Mark Zarate et al.· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.